M. Blombäck

1.2k total citations
46 papers, 1.0k citations indexed

About

M. Blombäck is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, M. Blombäck has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in M. Blombäck's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (8 papers). M. Blombäck is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (8 papers). M. Blombäck collaborates with scholars based in Sweden, United States and France. M. Blombäck's co-authors include Bengt Ljungberg, Hans Johnsson, Björn Dahlbäck, J.Fredrik Hesselvik, Joanna Chmielewska, Johan Malm, B. Wiman, Nils Egberg, N Lindvall and Pia Petrini and has published in prestigious journals such as European Heart Journal, Transplantation and Pure and Applied Chemistry.

In The Last Decade

M. Blombäck

45 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Blombäck Sweden 18 552 185 176 168 146 46 1.0k
PC Comp United States 14 1.2k 2.2× 287 1.6× 198 1.1× 301 1.8× 70 0.5× 19 1.4k
A. Schwarz Germany 6 409 0.7× 232 1.3× 225 1.3× 190 1.1× 105 0.7× 6 795
Jan J. Veltkamp Netherlands 14 735 1.3× 133 0.7× 172 1.0× 253 1.5× 96 0.7× 22 1.1k
Shu He Sweden 20 555 1.0× 316 1.7× 363 2.1× 250 1.5× 106 0.7× 42 1.1k
Kouzou Minamikawa Japan 14 339 0.6× 138 0.7× 113 0.6× 143 0.9× 91 0.6× 24 606
Hiroshi Jokaji Japan 17 334 0.6× 212 1.1× 150 0.9× 173 1.0× 123 0.8× 36 703
Chika Uotani Japan 18 363 0.7× 201 1.1× 202 1.1× 188 1.1× 117 0.8× 45 749
A. J. Webber Australia 11 391 0.7× 254 1.4× 372 2.1× 294 1.8× 104 0.7× 13 1.0k
E. C. M. van Pampus Netherlands 19 664 1.2× 263 1.4× 148 0.8× 414 2.5× 72 0.5× 29 1.1k
MB Hultin United States 20 1.4k 2.5× 247 1.3× 275 1.6× 163 1.0× 41 0.3× 32 1.6k

Countries citing papers authored by M. Blombäck

Since Specialization
Citations

This map shows the geographic impact of M. Blombäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Blombäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Blombäck more than expected).

Fields of papers citing papers by M. Blombäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Blombäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Blombäck. The network helps show where M. Blombäck may publish in the future.

Co-authorship network of co-authors of M. Blombäck

This figure shows the co-authorship network connecting the top 25 collaborators of M. Blombäck. A scholar is included among the top collaborators of M. Blombäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Blombäck. M. Blombäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulman, Sam, et al.. (2009). The plasma concentration of activated protein C appears normal in patients with haemophilia. Haemophilia. 15(2). 566–570. 3 indexed citations
2.
Blombäck, M., Barbara A. Konkle, Marilyn J. Manco‐Johnson, et al.. (2007). Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. Journal of Thrombosis and Haemostasis. 5(4). 855–858. 34 indexed citations
3.
Antović, Jovan P., Sam Schulman, In Bum Suh, Robert S. Greenfield, & M. Blombäck. (2004). Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?. Scandinavian Journal of Clinical and Laboratory Investigation. 64(8). 745–752. 6 indexed citations
5.
Blombäck, M., René Dybkær, Karsten Juhl Jørgensen, H. Olesen, & Steffen Ullitz Thorsen. (1997). Properties and units in the clinical laboratory sciences V. Properties and units in thrombosis and haemostasis (Technical Report). Pure and Applied Chemistry. 69(5). 1043–1080. 4 indexed citations
6.
Bremme, Katarina, M. Blombäck, Maria Bokarewa, G Falck, & Margareta Sten-Linder. (1995). THROMBOTIC RISK-FACTORS AND ORAL CONTRACEPTION (OC). Thrombosis and Haemostasis. 73(6). 1376–1376. 2 indexed citations
7.
Bremme, Katarina, et al.. (1995). Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. International Journal of Gynecology & Obstetrics. 50(2). 223–223. 60 indexed citations
8.
Blombäck, M., René Dybkær, Karsten Juhl Jørgensen, H. Olesen, & Steffen Ullitz Thorsen. (1995). International Society on Thrombosis and Haemostasis (ISTH), and International Union of Pure and Applied Chemistry (IUPAC), Clinical Properties and units in the clinical laboratory sciences. V. Properties and units in thrombosis and haemostasis (recommendation 1995). International Society on Thrombosis and Haemostasis (ISTH) and International Union of Pure and Applied Chemistry (IUPAC),and International Federation of Clinical Chemistry (IFCC).. PubMed. 33(9). 637–60. 1 indexed citations
9.
Bremme, Katarina, Henrik Lind, & M. Blombäck. (1993). The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy. International Journal of Gynecology & Obstetrics. 43(1). 93–93. 15 indexed citations
10.
Bremme, Katarina, et al.. (1992). Freezing Technique and Quality of Fresh-Frozen Plasma. Transfusion Medicine and Hemotherapy. 19(6). 283–287. 18 indexed citations
11.
Aronsson, B., et al.. (1992). Low levels of coagulation inhibitors in patients withClostridium difficile infection. Infection. 20(2). 58–60. 5 indexed citations
12.
Bremme, Katarina, et al.. (1992). Blood Component Processing Technique and Plasma Quality. Transfusion Medicine and Hemotherapy. 19(3). 110–114. 1 indexed citations
13.
Grip, Lars, M. Blombäck, & Sam Schulman. (1991). Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. European Heart Journal. 12(11). 1225–1233. 68 indexed citations
14.
Blombäck, M., et al.. (1990). Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. International Journal of Gynecology & Obstetrics. 31(3). 306–306. 1 indexed citations
15.
Brodin, B, et al.. (1985). Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.. PubMed. 178. 67–74. 9 indexed citations
16.
Brodin, B, et al.. (1985). Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.. PubMed. 178. 57–65. 6 indexed citations
17.
Frommel, D., et al.. (1981). HLA Antigens and Factor VIII Antibody in Classic Hemophilia. Thrombosis and Haemostasis. 46(4). 687–689. 13 indexed citations
18.
Soreff, Julius & M. Blombäck. (1980). ARTHROPATHY IN CHILDREN WITH SEVERE HEMOPHILIA A. Acta Paediatrica. 69(5). 667–673. 39 indexed citations
19.
Blombäck, M.. (1977). HOME TREATMENT OF HEMOPHILIAS IN SWEDEN. Scandinavian Journal of Haematology. 19(S31). 9–10. 1 indexed citations
20.
Blombäck, M., et al.. (1975). Dosage of i.v. Brinase in Man Based on Determination of the Brinase Inhibitor Capacity and Coagulation Studies. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026